CANCER PREVENTION AND CONTROL

COLLOQUIUM

Prophylactic Human Papillomavirus Vaccines        Allan Hildesheim, PhD   Speaker Dr. Hildesheim is a Senior Investigator in Division of Cancer Epidemiology and Genetics in the National Cancer Institute, National Institutes of Health, Bethesda, MD. Learning Objective To learn how to summarize evidence linking infection with human papillomaviruses (HPV) to the development of cervical cancer and will review pre-clinical and clinical data on promising HPV vaccines targeted at preventing HPV infection on their associate neoplasias. Target Audience Researchers and clinicians actively involved in topics that relate to cancer prevention and control Date/Time/Place Wednesday, March 23, 2005, 11:00 am Executive Plaza North Conference Room G 6130 Executive Boulevard Rockville, Maryland For Additional Information Office of Preventive Oncology 301-496-8640  If you are a person with a disability and require any assistive device, services or other reasonable accommodations to participate in this activity, please contact the Office of Preventive Oncology at 301-496-8640 at least one week in advance of the lecture date to discuss your accommodations needs.

The National Institutes of Health/Foundation for Advanced Education in the Sciences is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.